Medicare's $50 weight-loss drug program now runs through 2027
Published
KFF notes CMS pushed the end of the temporary Medicare GLP-1 Bridge from Dec. 31, 2026 to Dec. 31, 2027. People with Part D who meet weight and health criteria pay $50 a month for Wegovy, the Zepbound KwikPen or the Foundayo pill. The broader BALANCE model for Medicare has been delayed with no new start date. Ask your doctor whether you qualify.
Source: KFF
This is a plain-language summary. Read the original source for full details.